Amyloid deposition and advanced age fails to induce alzheimer's type progression in a double knock-in mouse model

Aging and Disease

Volumn 3, Issue 2, 2012, Pages 141-155

  Malthankar Phatak, Gauri H ^a   Lin, Yin Guo ^a   Giovannone, Nicholas ^a   Siman, Robert ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Aging; Alzheimer's disease; Amyloid; Cathepsin D; Neuronal degeneration; Tau

Indexed keywords

EID: 84872826790     PISSN: None     EISSN: 21525250     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. Games D, Adams D, Alessandrini R, Barbour R, Berthelette P, Blackwell C, Carr T, Clemens J, Donaldson T, Gillespie F (1995). Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein. Nature, 373:523-7.
2. Lamb BT (1995). Making models for Alzheimer's disease. Nat Genet, 9:4-6.
3. Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, Yang F, Cole G (1996). Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science, 274:99-102.
4. Sturchler-Pierrat C, Abramowski D, Duke M, Wiederhold KH, Mistl C, Rothacher S, Ledermann B, Burki K, Frey P, Paganetti PA, Waridel C, Calhoun ME, Jucker M, Probst A, Staufenbiel M, Sommer B (1997). Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc Natl Acad Sci U S A, 94:13287-92.
5. Holcomb L, Gordon MN, McGowan E, Yu X, Benkovic S, Jantzen P, Wright K, Saad I, Mueller R, Morgan D, Sanders S, Zehr C, O'Campo K, Hardy J, Prada CM, Eckman C, Younkin S, Hsiao K, Duff K (1998). Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nat Med, 4:97-100.
6. Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, Metherate R, Mattson MP, Akbari Y, LaFerla FM (2003). Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron, 39:409-21.
7. Stalder M, Phinney A, Probst A, Sommer B, Staufenbiel M, Jucker M (1999). Association of microglia with amyloid plaques in brains of APP23 transgenic mice. Am J Pathol, 154:1673-84.
8. Wirths O, Bayer TA (2010). Neuron loss in transgenic mouse models of Alzheimer's disease. Int J Alzheimers Dis, in press.
9. Malthankar-Phatak G, Poplawski S, Toraskar N, Siman R (2011). Combination therapy prevents amyloid-dependent and -independent structural changes. Neurobiol Aging, in press.
10. Staubli U, Ivy G, Lynch G (1984). Hippocampal denervation causes rapid forgetting of olfactory information in rats. Proc Natl Acad Sci U S A, 81:5885-7.
11. Sauvage MM, Beer Z, Ekovich M, Ho L, Eichenbaum H (2010). The caudal medial entorhinal cortex: a selective role in recollection-based recognition memory. J Neurosci, 30:15695-9.
12. Braak H, Braak E (1990). Neurofibrillary changes confined to the entorhinal region and an abundance of cortical amyloid in cases of presenile and senile dementia. Acta Neuropathol, 80:479-86.
13. Price JL, Ko AI, Wade MJ, Tsou SK, McKeel DW, Morris JC (2001). Neuron number in the entorhinal cortex and CA1 in preclinical Alzheimer disease. Arch Neurol, 58:1395-402.
14. Gomez-Isla T, Price JL, McKeel DW, Jr., Morris JC, Growdon JH, Hyman BT (1996). Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. J Neurosci, 16:4491-500.
15. Zhu Y, Hou H, Rezai-Zadeh K, Giunta B, Ruscin A, Gemma C, Jin J, Dragicevic N, Bradshaw P, Rasool S, Glabe CG, Ehrhart J, Bickford P, Mori T, Obregon D, Town T, Tan J (2011). CD45 deficiency drives amyloid-beta peptide oligomers and neuronal loss in Alzheimer's disease mice. J Neurosci, 31:1355-65.
16. Kocherhans S, Madhusudan A, Doehner J, Breu KS, Nitsch RM, Fritschy JM, Knuesel I (2010). Reduced Reelin expression accelerates amyloid-beta plaque formation and tau pathology in transgenic Alzheimer's disease mice. J Neurosci, 30:9228-40.
17. Lewis J, Dickson DW, Lin WL, Chisholm L, Corral A, Jones G, Yen SH, Sahara N, Skipper L, Yager D, Eckman C, Hardy J, Hutton M, McGowan E (2001). Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science, 293:1487-91.
18. Ribe EM, Perez M, Puig B, Gich I, Lim F, Cuadrado M, Sesma T, Catena S, Sanchez B, Nieto M, Gomez-Ramos P, Moran MA, Cabodevilla F, Samaranch L, Ortiz L, Perez A, Ferrer I, Avila J, Gomez-Isla T (2005). Accelerated amyloid deposition, neurofibrillary degeneration and neuronal loss in double mutant APP/tau transgenic mice. Neurobiol Dis, 20:814-22.
19. Yang Y, Geldmacher DS, Herrup K (2001). DNA replication precedes neuronal cell death in Alzheimer's disease. J Neurosci, 21:2661-8.
20. Cataldo AM, Hamilton DJ, Nixon RA (1994). Lysosomal abnormalities in degenerating neurons link neuronal compromise to senile plaque development in Alzheimer disease. Brain Res, 640:68-80.
21. Reaume AG, Howland DS, Trusko SP, Savage MJ, Lang DM, Greenberg BD, Siman R, Scott RW (1996). Enhanced amyloidogenic processing of the beta-amyloid precursor protein in gene-targeted mice bearing the Swedish familial Alzheimer's disease mutations and a "humanized" Abeta sequence. J Biol Chem, 271:23380-8.
22. Siman R, Reaume AG, Savage MJ, Trusko S, Lin YG, Scott RW, Flood DG (2000). Presenilin-1 P264L knock-in mutation: differential effects on abeta production, amyloid deposition, and neuronal vulnerability. J Neurosci, 20:8717-26.
23. Siman R, Flood DG, Thinakaran G, Neumar RW (2001). Endoplasmic reticulum stress-induced cysteine protease activation in cortical neurons: effect of an Alzheimer's disease-linked presenilin-1 knock-in mutation. J Biol Chem, 276:44736-43.
24. Flood DG, Reaume AG, Dorfman KS, Lin YG, Lang DM, Trusko SP, Savage MJ, Annaert WG, De Strooper B, Siman R, Scott RW (2002). FAD mutant PS-1 gene-targeted mice: increased A beta 42 and A beta deposition without APP overproduction. Neurobiol Aging, 23:335-48.
25. Siman R, Salidas S (2004). Gamma-secretase subunit composition and distribution in the presenilin wild-type and mutant mouse brain. Neuroscience, 129:615-28.
26. Savage MJ, Iqbal M, Loh T, Trusko SP, Scott R, Siman R (1994). Cathepsin G: localization in human cerebral cortex and generation of amyloidogenic fragments from the beta-amyloid precursor protein. Neuroscience, 60:607-19.
27. D'Arcangelo G, Miao GG, Chen SC, Soares HD, Morgan JI, Curran T (1995). A protein related to extracellular matrix proteins deleted in the mouse mutant reeler. Nature, 374:719-23.
28. Mullen RJ, Buck CR, Smith AM (1992). NeuN, a neuronal specific nuclear protein in vertebrates. Development, 116:201-11.
29. Jicha GA, Bowser R, Kazam IG, Davies P (1997). Alz-50 and MC-1, a new monoclonal antibody raised to paired helical filaments, recognize conformational epitopes on recombinant tau. J Neurosci Res, 48:128-32.
30. Yang Y, Varvel NH, Lamb BT, Herrup K (2006). Ectopic cell cycle events link human Alzheimer's disease and amyloid precursor protein transgenic mouse models. J Neurosci, 26:775-84.
31. Cataldo AM, Barnett JL, Berman SA, Li J, Quarless S, Bursztajn S, Lippa C, Nixon RA (1995). Gene expression and cellular content of cathepsin D in Alzheimer's disease brain: evidence for early up-regulation of the endosomal-lysosomal system. Neuron, 14:671-80.
32. Franklin KBJ, Paxinos G. The Mouse Brain in Stereotaxic Coordinates. 3rd ed. New York NY: Academic Press; 2008.
33. Hyman BT, Van Hoesen GW, Kromer LJ, Damasio AR (1986). Perforant pathway changes and the memory impairment of Alzheimer's disease. Ann Neurol, 20:472-81.
34. Braak H, Braak E (1991). Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol, 82:239-59.
35. Ramos-Moreno T, Galazo MJ, Porrero C, Martinez-Cerdeno V, Clasca F (2006). Extracellular matrix molecules and synaptic plasticity: immunomapping of intracellular and secreted Reelin in the adult rat brain. Eur J Neurosci, 23:401-22.
36. van Groen T, Kadish I, Wyss JM (2002). Species differences in the projections from the entorhinal cortex to the hippocampus. Brain Res Bull, 57:553-6.
37. Hock BJ, Jr., Lamb BT (2001). Transgenic mouse models of Alzheimer's disease. Trends Genet, 17:S7-12.
38. Higuchi M, Zhang B, Forman MS, Yoshiyama Y, Trojanowski JQ, Lee VM (2005). Axonal degeneration induced by targeted expression of mutant human tau in oligodendrocytes of transgenic mice that model glial tauopathies. J Neurosci, 25:9434-43.
39. Cataldo AM, Paskevich PA, Kominami E, Nixon RA (1991). Lysosomal hydrolases of different classes are abnormally distributed in brains of patients with Alzheimer disease. Proc Natl Acad Sci U S A, 88:10998-1002.
40. Arendt T, Holzer M, Stobe A, Gartner U, Luth HJ, Bruckner MK, Ueberham U (2000). Activated mitogenic signaling induces a process of dedifferentiation in Alzheimer's disease that eventually results in cell death. Ann N Y Acad Sci, 920:249-55.
41. Herrup K, Arendt T (2002). Re-expression of cell cycle proteins induces neuronal cell death during Alzheimer's disease. J Alzheimers Dis, 4:243-7.
42. Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R, Hansen LA, Katzman R (1991). Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol, 30:572-80.
43. Goedert M (1995). Molecular dissection of the neurofibrillary lesions of Alzheimer's disease. Arzneimittelforschung, 45:403-9.
44. Vincent I, Zheng JH, Dickson DW, Kress Y, Davies P (1998). Mitotic phosphoepitopes precede paired helical filaments in Alzheimer's disease. Neurobiol Aging, 19:287-96.
45. Chin J, Massaro CM, Palop JJ, Thwin MT, Yu GQ, Bien-Ly N, Bender A, Mucke L (2007). Reelin depletion in the entorhinal cortex of human amyloid precursor protein transgenic mice and humans with Alzheimer's disease. J Neurosci, 27:2727-33.
46. Games D, Buttini M, Kobayashi D, Schenk D, Seubert P (2006). Mice as models: transgenic approaches and Alzheimer's disease. J Alzheimers Dis, 9:133-49.
47. Ashe KH, Zahs KR (2010). Probing the biology of Alzheimer's disease in mice. Neuron, 66:631-45.
48. Morris JC, Roe CM, Grant EA, Head D, Storandt M, Goate AM, Fagan AM, Holtzman DM, Mintun MA (2009). Pittsburgh compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer disease. Arch Neurol, 66:1469-75.
49. Weiner MW, Aisen PS, Jack CR, Jr., Jagust WJ, Trojanowski JQ, Shaw L, Saykin AJ, Morris JC, Cairns N, Beckett LA, Toga A, Green R, Walter S, Soares H, Snyder P, Siemers E, Potter W, Cole PE, Schmidt M (2010). The Alzheimer's disease neuroimaging initiative: progress report and future plans. Alzheimers Dement, 6:202-11.
50. Tarawneh R, Holtzman DM (2010). Biomarkers in translational research of Alzheimer's disease. Neuropharmacology, 59:310-22.
51. Loerch PM, Lu T, Dakin KA, Vann JM, Isaacs A, Geula C, Wang J, Pan Y, Gabuzda DH, Li C, Prolla TA, Yankner BA (2008). Evolution of the aging brain transcriptome and synaptic regulation. PLoS One, 3:e3329.
52. Vitek MP, Snell J, Dawson H, Colton CA (1997). Modulation of nitric oxide production in human macrophages by apolipoprotein-E and amyloid-beta peptide. Biochem Biophys Res Commun, 240:391-4.
53. Schwab C, Hosokawa M, McGeer PL (2004). Transgenic mice overexpressing amyloid beta protein are an incomplete model of Alzheimer disease. Exp Neurol, 188:52-64.
54. nd edition. Florida: CRC Press, Chapter 1.
55. Bettens K, Sleegers K, Van Broeckhoven C (2010). Current status on Alzheimer disease molecular genetics: from past, to present, to future. Hum Mol Genet, 19:R4-R11.
56. Wilcox KC, Lacor PN, Pitt J, Klein WL (2011). Abeta Oligomer-Induced Synapse Degeneration in Alzheimer's Disease. Cell Mol Neurobiol, in press.
57. Yoshiyama Y, Higuchi M, Zhang B, Huang SM, Iwata N, Saido TC, Maeda J, Suhara T, Trojanowski JQ, Lee VM (2007). Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron, 53:337-51.
58. Vincent I, Jicha G, Rosado M, Dickson DW (1997). Aberrant expression of mitotic cdc2/cyclin B1 kinase in degenerating neurons of Alzheimer's disease brain. J Neurosci, 17:3588-98.
59. Busser J, Geldmacher DS, Herrup K (1998). Ectopic cell cycle proteins predict the sites of neuronal cell death in Alzheimer's disease brain. J Neurosci, 18:2801-7.
60. Nixon RA, Wegiel J, Kumar A, Yu WH, Peterhoff C, Cataldo A, Cuervo AM (2005). Extensive involvement of autophagy in Alzheimer disease: an immuno-electron microscopy study. J Neuropathol Exp Neurol, 64:113-22.
61. Yu WH, Cuervo AM, Kumar A, Peterhoff CM, Schmidt SD, Lee JH, Mohan PS, Mercken M, Farmery MR, Tjernberg LO, Jiang Y, Duff K, Uchiyama Y, Naslund J, Mathews PM, Cataldo AM, Nixon RA (2005). Macroautophagy--a novel Beta-amyloid peptide-generating pathway activated in Alzheimer's disease. J Cell Biol, 171:87-98.
62. Cataldo AM, Peterhoff CM, Schmidt SD, Terio NB, Duff K, Beard M, Mathews PM, Nixon RA (2004). Presenilin mutations in familial Alzheimer disease and transgenic mouse models accelerate neuronal lysosomal pathology. J Neuropathol Exp Neurol, 63:821-30.
63. Shen J, Kelleher RJ, III (2007). The presenilin hypothesis of Alzheimer's disease: evidence for a loss-of-function pathogenic mechanism. Proc Natl Acad Sci U S A, 104:403-9.